关键词:膀胱肿瘤;基因;免疫组织化学
【摘要 】 目的 探讨癌基因MDM2 和抑癌基因p53在膀胱癌中的表达及其临床价值。 方法 采用免疫组织化学方法对23例膀胱癌标本进行检测。 结果 MDM2 、p53基因蛋白在肿瘤中阳性表达为39%和48%,与肿瘤分级分期,肿瘤复发性相关,两者异常表达呈负相关(r=-0.2946,P<0 .05)。两者在癌旁组织中亦有一定表达率。 结论 MDM2 、p53基因的异常表达是膀胱癌中的基因事件,与膀胱癌发生发展密切相关,可作为临床判断肿瘤进展及可能预后的瘤标。
Expression of MDM2 and p53 genein human bladder cancer
LI Zhonghua, ZHAO JianXing, ZHANG Shichun.Department of Urology,Xiang Ya Hospital,HunanMedical University,Changsha 410008
【Abstract 】 Objective Tostudy the expression of MDM2 and p53 gene and their significance in humanbladder cancer. Methods Immunohistochemical technique was used tostudy the expression of MDM2 and p53 gene in 23 cases of transitional cellbladder carcinoma and in th eir matched adjacent normal transitional epithelium. Results The positive expression rates of MDM2 and p53 were 39% and 48% and werecorrelated with tumor grade,tumor stage and tumor relapse.MDM2 was negativelycorrelated with p53 gene.Both MDM2 and p53 had a certain expression rate in theepithelium adjacent to the tumor. Conclusions Aberrant MDM2 and p53 are frequent genetic events in bladder cancer and might be closely correlated withtumorigenesis and/or tumor progression in urothelial neoplasm s.Aberrant MDM2 and p53 phenotypes might serve as a marker of the progression and prognosis of bladdercancer and might provde a theoretical explanation for the easy relapse of transitionalcell carcinoma.
......
您现在查看是摘要页,全文长 9846 字符。